DCU success in Shared Island North-South Research Programme
dcu.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dcu.ie Daily Mail and Mail on Sunday newspapers.
DCU researchers discover new method to provide effective DNA damaging cancer treatments
dcu.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dcu.ie Daily Mail and Mail on Sunday newspapers.
Share:
SHANNON, Ireland, May 04, 2021 (GLOBE NEWSWIRE) PBC Biomed, an Irish-based Medical Device Company, will lead a consortium comprised of Biodesign Europe and SFI Research Centre for Advanced Manufacturing (I-Form) at Dublin City University and Dolmen Design & Innovation, a Dublin-based product design company, in developing a bone adhesive for the treatment of osteoporotic fractures. This partnership was recently awarded €3.4M by the Irish Governments Disruptive Technologies Innovation Fund (DTIF), with an additional €2M investment from the industry partners associated with the project.
PBC Biomed, located in Shannon with a US office in Memphis, Tennessee, is focused on accelerating medical innovation in the areas of bone and tissue healing through partnerships with healthcare professionals, academic institutions and medtech companies. The development of a bone adhesive that will significantly reduce operating times, risk of infection, and the need for hardware in compl
PBC Biomed to lead consortium in development of bone adhesive
May 04, 2021 04:00 ET | Source: PBC Biomed Ltd PBC Biomed Ltd Shannon, IRELAND
SHANNON, Ireland, May 04, 2021 (GLOBE NEWSWIRE) PBC Biomed, an Irish-based Medical Device Company, will lead a consortium comprised of Biodesign Europe and SFI Research Centre for Advanced Manufacturing (I-Form) at Dublin City University and Dolmen Design & Innovation, a Dublin-based product design company, in developing a bone adhesive for the treatment of osteoporotic fractures. This partnership was recently awarded €3.4M by the Irish Governments Disruptive Technologies Innovation Fund (DTIF), with an additional €2M investment from the industry partners associated with the project.